| Business: |
(Incorporated in the Cayman Islands)
We are a newly organized blank check company. We intend to focus our search on companies with global operations and differentiated technology or capabilities, particularly in healthcare, biotechnology, advanced manufacturing, robotics, artificial intelligence, and related sectors.
J. Douglas Ramsey, Ph.D., has served as our chairman, CEO and CFO since August 2025. From June 2020 until August 2025, Dr. Ramsey was the Chairman, Chief Executive Officer and Chief Financial Officer of Breeze Holdings Acquisition Corp. which merged with YD Biopharma Limited, a Taiwan-based company focused on early cancer detection. Since August 2025, Dr. Ramsey has served as a director of YD Bio Limited, the publicly traded parent company of the merged entities.
Dr. Ramsey was the President and Chief Financial Officer of Saddle Operating and served in that role from May 2014 until February 2019. Prior to joining Saddle Operating, Dr. Ramsey served as the Director of Strategic Planning and Special Projects of EXCO from June 2013 until April 2014, Vice President — Finance and Special Assistant to the Chairman of EXCO Resources from August 2009 until May 2013, and as Treasurer of EXCO Resources from December 1997 until May 2013. From December 1997 until July 2009, Dr. Ramsey served as EXCO Resources’ Chief Financial Officer during which time EXCO Resources completed over 160 transactions in the U.S. and Canada, and its assets grew from $3 million to over $6 billion with over 15,000 wells and more than 1,400 employees and contractors. Dr. Ramsey also played a key role in EXCO Resources’ $698 million IPO in February 2006 after EXCO Resources had gone private in July 2003.
(Note: Breeze Acquisition Corp. II filed its S-1 for tis SPAC IPO on Nov. 17, 2025, and disclosed the terms: 12.5 million units at $10.00 each to raise $125 million. Each unit consists of one share of stock and the right to receive one-tenth (1/10th) of a share upon the completion of an initial business combination.)
|
